4880 CellSource Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4880

TSE Prime

CellSource Co., Ltd.

435

JPY

-46

(-9.56%)

Dec 12, 3:30 pm JST

2.79

USD

Dec 12, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct, 2022	4,273	1,571	1,583	1,017	54.5	0	Dec 14, 2022	J-GAAP
Oct, 2023	4,510	1,221	1,194	923	48.9	20	Dec 15, 2023	J-GAAP
Oct, 2024	4,355	129	236	237	12.0	5	Dec 12, 2024	J-GAAP
Oct, 2025	3,711	166	167	10	0.5	5	Dec 11, 2025	J-GAAP
Oct, 2026 Guidance	3,418	-170	-164	-136	-6.9	0	Dec 11, 2025	J-GAAP
YoY	-7.9%	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Oct, 2021	Dec 14, 2020	2,539	573	570	356	0*	J-GAAP
	Jun 14, 2021	2,810	759	771	474	0*	J-GAAP
	Dec 8, 2021	2,922	992	1,006	651	0*	J-GAAP
Results	Dec 13, 2021	2,922	992	1,006	651	0*	J-GAAP
Oct, 2022	Dec 13, 2021	Available in future release
	Aug 31, 2022
Results	Dec 14, 2022
Oct, 2023	Dec 14, 2022
	Sep 19, 2023
Results	Dec 15, 2023
Oct, 2024	Dec 15, 2023
	Sep 12, 2024
Results	Dec 12, 2024
Oct, 2025	Dec 12, 2024
	Sep 11, 2025
Results	Dec 11, 2025
Oct, 2026	Dec 11, 2025	3,418	-170	-164	-136	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct, 2016	139	－	Available in future release
Oct, 2017	519	+273.4
Oct, 2018	1,212	+133.5
Oct, 2019	1,611	+32.9
Oct, 2020	1,855	+15.1
Oct, 2021	2,922	+57.5
Oct, 2022	4,273	+46.2
Oct, 2023	4,510	+5.5
Oct, 2024	4,355	-3.4
Oct, 2025	3,711	-14.8
Oct, 2026 Guidance	3,418	-7.9	-170	－	-164	－	-6.9	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Oct, 2024	4,355	129	2.96	3.90	3.40	0.62	12.0
Oct, 2025	3,711	166	4.47	0.17	0.14	0.53	0.5
Oct, 2026 Guidance	3,418	-170	-5.0	-2.30	-1.94	0.49	-6.9

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	4,510	1,571	1,583	1,017	54.5
Fiscal Year	Oct, 2023	Oct, 2022	Oct, 2022	Oct, 2022	Oct, 2022

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Nov - Apr, 2022	2,170	659	650	410	21.9	0	Jun 14, 2023	J-GAAP
Nov - Apr, 2023	2,227	281	388	299	15.2	0	Jun 13, 2024	J-GAAP
Nov - Apr, 2024	1,820	17	18	11	0.6	0	Jun 12, 2025	J-GAAP
Nov - Apr, 2025 Guidance	ー	ー	ー	ー	－	0	Dec 11, 2025	J-GAAP
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Apr, 2023	Dec 14, 2022	ー	ー	ー	ー	0	J-GAAP
- - - - Results	Jun 14, 2023	2,170	659	650	410	0	J-GAAP
Apr, 2024	Dec 15, 2023	Available in future release
Results	Jun 13, 2024
Apr, 2025	Dec 12, 2024
Results	Jun 12, 2025
Apr, 2026	Dec 11, 2025	ー	ー	ー	ー	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Oct, 2023	1,221	222	846	-624	1,449	4,781	69.50	J-GAAP
Oct, 2024	129	-23	591	-614	-437	4,320	61.07	J-GAAP
Oct, 2025	166	330	333	-3	61	4,711	67.08	J-GAAP

Actual Performance and Financial Trends

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct, 2023	4,510	1,221	1,194	923	48.9	20	Dec 15, 2023	J-GAAP
Oct, 2024	4,355	129	236	237	12.0	5	Dec 12, 2024	J-GAAP
Oct, 2025	3,711	166	167	10	0.5	5	Dec 11, 2025	J-GAAP
YoY	-14.8%	+28.7%	-29.2%	-95.8%	-95.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Nov - Jan, 2023	1,173	205	208	143	7.3	17.5	Mar 11, 2024	J-GAAP
Feb - Apr, 2024	1,054	76	180	156	7.9	7.2	Jun 13, 2024	J-GAAP
May - Jul, 2024	1,114	107	107	75	3.8	9.6	Sep 12, 2024	J-GAAP
Aug - Oct, 2024	1,014	-259	-259	-137	-7.0	-25.5	Dec 12, 2024	J-GAAP
Nov - Jan, 2024	849	-62	-60	-45	-2.3	-7.3	Mar 11, 2025	J-GAAP
Feb - Apr, 2025	971	79	78	56	2.9	8.1	Jun 12, 2025	J-GAAP
May - Jul, 2025	998	106	109	75	3.8	10.6	Sep 11, 2025	J-GAAP
Aug - Oct, 2025	893	43	40	-76	-4.1	4.8	Dec 11, 2025	J-GAAP
YoY	-11.9%	－	－	+44.5%	+41.0%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Nov - Jan, 2020	622	+40.1	Available in future release
Feb - Apr, 2021	721	+63.1
May - Jul, 2021	761	+79.1
Aug - Oct, 2021	818	+50.4
Nov - Jan, 2021	820	+31.8
Feb - Apr, 2022	877	+21.6
May - Jul, 2022	1,175	+54.4
Aug - Oct, 2022	1,401	+71.3
Nov - Jan, 2022	1,059	+29.1
Feb - Apr, 2023	1,111	+26.7
May - Jul, 2023	1,236	+5.2
Aug - Oct, 2023	1,104	-21.2
Nov - Jan, 2023	1,173	+10.8
Feb - Apr, 2024	1,054	-5.1
May - Jul, 2024	1,114	-9.9
Aug - Oct, 2024	1,014	-8.2
Nov - Jan, 2024	849	-27.6
Feb - Apr, 2025	971	-7.9
May - Jul, 2025	998	-10.4
Aug - Oct, 2025	893	-11.9	43	－	40	－	-4.1	+41.4

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,401	633	637	428	23.0
Fiscal Year	Oct, 2022	Oct, 2022	Oct, 2022	Oct, 2022	Oct, 2022

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Oct, 2023	311.25	89.4	6,879	6,150	3,377	0.02	Dec 15, 2023	J-GAAP
Oct, 2024	302.52	84.7	7,074	5,991	3,220	0.01	Dec 12, 2024	J-GAAP
Oct, 2025	297.80	84.0	7,023	5,902	3,131	0.01	Dec 11, 2025	J-GAAP

CellSource Co., Ltd.(4880) Financial Results